1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pirtobrutinib (LOXO-305), a next generation highly selective non-covalent Bruton's tyrosine kinase inhibitor in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the Phase 1/2 BRUIN study
    Meeting Abstract

    Eyre, T.; Pagel, J. M.; Coombs, C. C.; Shah, N. N.; Lamanna, N.; Lech-Maranda, E.; Woyach, J.; Wierda, W. G.; Cheah, C. Y.; Roeker, L.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Cost-effectiveness analysis of no adjuvant therapy versus partial breast irradiation alone versus combined treatment for treatment of low-risk DCIS
    Meeting Abstract

    Shah, C.; Ward, M.; Vicini, F.; Al-Hilli, Z.; Chadha, M.; Abraham, A.; Greenberg, Z.; Recht, A.; Hayman, J.; Thaker, N.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Long-term survivors and gilteritinib safety beyond 1 year in patients with FLT3-mutated relapsed or refractory acute myeloid leukemia: ADMIRAL trial follow-up
    Meeting Abstract

    Perl, A. E.; Martinelli, G.; Neubauer, A.; Berman, E.; Baer, M. R.; Larson, R. A.; Fathi, A. T.; Yokoyama, H.; Hosono, N.; Hasabou, N.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Addition of parsaclisib (INCB050465), a PI3K delta inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis
    Meeting Abstract

    Yacoub, A.; Wang, E.; Rampal, R.; Borate, U.; Kremyanskaya, M.; Ali, H.; Hobbs, G.; O'Connell, C.; Assad, A.; Erickson-Viitanen, S.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel in relapsed/refractory multiple myeloma
    Meeting Abstract

    Madduri, D.; Berdeja, J.; Usmani, S.; Jakubowiak, A.; Agha, M.; Cohen, A.; Stewart, A. K.; Hari, P.; Htut, M.; O'Donnell, E.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Factors associated with margin re-excision in oncoplastic surgery for breast cancer
    Meeting Abstract

    Verdial, F. C.; Pawloski, K. R.; Sevilimedu, V.; Mehrara, B. J.; Gemignani, M. L.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • HER2CLIMB-02: Tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer
    Meeting Abstract

    Hurvitz, S. A.; Harbeck, N.; Vahdat, L.; Wolff, A. C.; Tolaney, S. M.; Loi, S.; Masuda, N.; O'Shaughnessy, J.; Xie, D.; Walker, L. N.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Routine perioperative and post-discharge use of non-steroidal anti-inflammatory drugs: What is the risk of hematoma after lumpectomy and sentinel lymph node biopsy?
    Meeting Abstract

    Pawloski, K. R.; Matar, R.; Sevilimedu, V.; Tadros, A. B.; Kirstein, L.; Cody, H.; Van Zee, K.; Morrow, M.; Moo, T. A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • The effect of age on outcomes after neoadjuvant chemotherapy for breast cancer
    Meeting Abstract

    Verdial, F. C.; Mamtani, A.; Pawloski, K. R.; Sevilimedu, V.; Gemignani, M.; Barrio, A. V.; Morrow, M.; Tadros, A. B.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Analysis of ctDNA in advanced breast cancer reveals polyclonal disease associated with adverse outcome
    Meeting Abstract

    Kingston, B.; Cutts, R.; Beaney, M.; Walsh-Crestani, G.; Hrebien, S.; Kilburn, L.; Kernaghan, S.; Moretti, L.; Wilkinson, K.; MacPherson, I.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save